We would love to hear your thoughts about our site and services, please take our survey here.
Rule applies to US companies based on incorporation, not listing.
Yes. I appear to have received the equivalent of 7.44p per share.
I have paid withholding tax as my shares are in an ISA; those holding in a SIPP should receive more (roughly 10.63p I think).
Yesterday's RNS has not been remarked on here, but I for one thought it was very encouraging that a non-exec director saw fit to purchase £1m of shares!
SMDS seems to be establishing upwards SP momentum...
Those accounts (up to 30 Nov 2020) are for the UK company and as I understand it, so far any product sales will have been made out of the US subsidiary? If the UK company is basically just a holding company then the main performance metric is the "fair value gain/loss" of the financial assets i.e. the shares in the underlying company: in the accounts to 30 Nov 2021, this was recorded as neither a gain nor loss. There are also zero sales out of the UK company in the latest accounts: again presumably because it's the US subsidiary that is actually selling products.
Happy to be corrected if this is not right.
Spot on, MaximusD.
So many UK investors think all small companies need a single "breakthrough" moment when the share price explodes, like when a miner/driller announces a significant finding.
The trajectory is far more important for a company like Microsalt (not called Salarius any more). It is a disruptive product, in an enormous market where innovation is needed to meet increasing regulatory focus on salt content.
Sure, on any objective view the Presty deal is small. But I think that's to be expected really: small players often make quicker decisions about using new ingredients etc.
Hopefully one day there will be deals with the likes of Pepsico, Nestle & Mondelez ; but in the meantime this kind of announcement is encouraging!
Not sure they get any revenue from that: I could be wrong but I think that is part of their USP as OEM, compared with "competitors" who have simply tried to reverse engineer individual pieces of equipment.
(1) Inflation. All that was stated in the recent results presentation was: "The Company mostly offset higher expenses compared to H1 2021 from a higher headcount and cost inflation with 2022 price increases and improved operational efficiency." I can't speak to ongoing contracts etc. I'm not really sure what kind of long-term contracts SOM would enter?
(2) Robotics. I'm not sure about this, but have a hunch that at least for some time, the cost of better floors will be smaller than the cost of better warehouse robots. I'm not really sure that the business model is dependent on warehouses suitable for robots. Perhaps others can assist.
In my view, a bigger immediate issue is the US cement shortage that is creating a delay in concrete being available for jobs, slowing contractors' progress. SOM say if it persists it could affect 2023 trading somewhat, but it's unclear to what extent and might be offset by delayed orders which were still to be filled as at the end of H1 '22.
I have nevertheless topped up today.
I bought in early July at 392p. After a boost from the recent Questor tip, the market now seems to be waiting for a meaningful indication of the company's near-term fortunes (given wider economic turmoil), and confirmation of the interim dividend. Seems to be a well-run company.
There would seem to be some confusion about whether this board is for investment-related discussion or consumer complaints.
I'd like to know too. Am a recent buyer and bought a multiple of 17 so as not to miss out on the maximum amount of additional shares! I hadn't considered whether the record date could be set retrospectively. Doesn't really make sense to me in terms of SP management, but what do I know.
And executives whose remuneration is often based around earnings per share. With fewer shares in circulation, EPS goes up automatically despite no material improvement in financial performance!
Well in the end I bought two modest tranches in Oct and Nov at an average of 1140p, when there was a discount to NAV of 1-4%. Decided the OCF was worth it and could come down as the assets grow and/or new shares are issued. From back of fag packet calculations I think we are this moment trading at a premium of around 3% and I've seen a gain of about 13% already. The underlying assets - if you track them - are clearly volatile but very promising.
If you read what Terry has said about ETFs tracking the EM indices and how the trust varies vastly in comparison to the composition of other EM funds/trusts, it is unsurprising. If you are not willing to tolerate underperformance in any given period, I would suggest Fundsmith is not for you! I am considering whether to buy in now as a long-term investment (15+ years), especially given the shares are now on a small discount to NAV. My only hesitation is the fairly high OCF.
Is the group really structured in such a way that Sunbelt has profits that are subject to US corp tax?!
Well we've now touched MTB's end of year target price at least twice today! Whither henceforth?!
...and raise their target price from 710p to 730p! Along with that sell rating.
From us Ashtead investors! Long may he build.
AHT was tipped as a buy by Questor today: http://www.telegraph.co.uk/investing/shares/questor-share-tip-back-ashtead-to-grow-its-dividends-no-matter-t/ Worth a read. Unfortunately my browser won't let me copy and paste.
Thanks Dubious. As I hold through my HL ISA, it sounds like I will need to call the company to find out. First held these a few years ago when investing for the first time. I was actually "saving" for a house deposit and somehow managed to make no money whatsoever (my Mrs got worried we could lose everything so to keep her happy I sold just before they shot up!). Now we've got the house I bought some more AHT shares in the last year between around 8.90 and 10.00. So I've finally made some money on AHT despite having first had some shares over three years ago!